{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-108353","form_type":"8-K","ticker":"CLYD","cik":"0002094256","company_name":"BEACON TOPCO, INC.","filed_at":"2026-09-16T23:54:59+00:00","discovered_at":"2026-09-17T10:05:00.790431+00:00","generated_at":"2026-09-17T10:05:48.023020+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Beacon Topco completes Barinthus Bio acquisition; launches $15M share tender offer","bullets":["Acquisition of Barinthus Biotherapeutics closed via UK scheme of arrangement effective Sept 9, 2026; Barinthus now wholly-owned subsidiary.","Cash tender offer launched Sept 15, 2026 to buy up to $15M of Beacon Topco common stock at $6.6609 per share, net to seller, no interest.","Amended and restated certificate of incorporation adopted effective Sept 9, 2026; amended and restated bylaws effective Sept 8, 2026.","Merger Agreement dated Sept 29, 2025, as amended Feb 22, 2026, governed the transaction."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-108353","json":"https://secwatch.observer/filing/0001104659-26-108353.json","markdown":"https://secwatch.observer/filing/0001104659-26-108353.md","text":"https://secwatch.observer/filing/0001104659-26-108353.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2094256/000110465926108353/0001104659-26-108353-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2094256/000110465926108353/tm2625583d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-17T10:05:48.023020+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}